Cluster and Descriptive Costs (n) | CCS Disease Categories in the Pre-HD Period (%) | CCS Disease Categories in the Post-HD Period (%) |
---|---|---|
Cluster 1: Average to High (n = 113) | 1. Acute and unspecified ESRD (82 %) 2. CKD (67 %) 3. Essential hypertension (61 %) 4. Other lower respiratory disease (60 %) 5. Other connective tissue disease (60 %) 6. Deficiency and other anemia (58 %) 7. Residual codes; unclassified (57 %) 8. Type 2 diabetes without complication (56 %) 9. Other circulatory disease (54 %) 10. Cardiac dysrythmias (52 %) | 1. CKD (99 %) 2. Acute and unspecified ESRD (90 %) 3. Deficiency and other anemia (89 %) 4. Septicemia (except in labor) (89 %) 5. Complication of device, implant, or graft (86 %) 6. Residual codes; unclassified (83 %) 7. Respiratory failure; insufficiency; arrest (adult) (82 %) 8. Other circulatory disease (80 %) 9. Other lower respiratory disease (78 %) 10. Cardiac dysrhythmias (76 %) |
Cluster 2: Very High to High (n = 89) | 1. Acute and unspecified ESRD (87 %) 2. Other lower respiratory disease (80 %) 3. Respiratory failure; insufficiency; arrest (78 %) 4. Residual codes; unclassified (75 %) 5. Cardiac dysrythmias (73 %) 6. Essential hypertension (70 %) 7. Septicemia (67 %) 8. Deficiency and other anemia (65 %) 9. CKD (65 %) 10. Other circulatory disease (64 %) | 1. CKD (97 %) 2. Acute and unspecified ESRD (89 %) 3. Deficiency and other anemia (85 %) 4. Respiratory failure; insufficiency; arrest (78 %) 5. Residual codes; unclassified (78 %) 6. Complication of device, implant or graft (76 %) 7. Essential hypertension (75 %) 8. Other aftercare (73 %) 9. Other lower respiratory disease (72 %) 10. Other connective tissue disease (72 %) |
Cluster 3: Average to Average (n = 16,624) | 1. CKD (92 %) 2. Deficiency and other anemia (69 %) 3. Essential hypertension (60 % 4. Hypertension with complications and secondary hypertension (59 %) 5. Acute and unspecified ESRD (57 %) 6. Type 2 diabetes without complications (475) 7. Type 2 diabetes with complications (42 %) 8. Residual codes; unclassified (41 %) 9. Other lower respiratory disease (40 %) 10. Complication of device; implant or graft (37 %) | 1. CKD (100 %) 2. Deficiency and other anemia (86 %) 3. Complication of device; implant or graft (73 %) 4. Hypertension with complications and secondary hypertension (70 %) 5. Essential hypertension (62 %) 6. Acute and unspecified ESRD (55 %) 7. Other disease of kidney and ureters (53 %) 8. Type 2 diabetes without complication (50 %) 9. Residual codes; unclassified (50 %) 10. Type 2 diabetes with complications (45 %) |
Cluster 4: Increasing Costs, High at Both Points (n = 1554) | 1. CKD (85 %) 2. Acute and unspecified ESRD (70 %) 3. Deficiency and other anemia (66 %) 4. Essential hypertension (65 %) 5. Hypertension with complications and secondary hypertension (58 %) 6. Residual codes; unclassified (52 %) 7. Type 2 diabetes without complication (52 %) 8. Other lower respiratory disease (51 %) 9. Type 2 diabetes with complications (50 %) 10. Fluid and electrolyte disorders (45 %) | 1. CKD (92 %) 2. Deficiency and other anemia 3. Hypertension with complications and secondary hypertension 4. Complication of device; implant or graft 5. Residual codes; unclassified 6. Acute and unspecified ESRD 7. Essential hypertensions 8. Other aftercare 9. Other circulatory disorder 10. Other lower respiratory disease |